Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing
Market News Market Pulse Stocks News ETF News Crypto News

Supernus Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Supernus Pharmaceuticals, Inc.

Sep-02
Supernus Pharmaceuticals to Participate in September Investor Conferences SUPN GlobeNewswire
Aug-31
Chloe Kim Teams Up with Qelbree, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD SUPN GlobeNewswire
Aug-03
Supernus Announces Second Quarter 2026 Financial Results SUPN GlobeNewswire
Jul-22
Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026 SUPN GlobeNewswire
Jul-14
Supernus Celebrates Five-Year Anniversary of Qelbree FDA Approval, Continuing to Deliver on Real-World Experience in ADHD SUPN GlobeNewswire
May-27
Supernus Pharmaceuticals to Participate in June Investor Conferences SUPN GlobeNewswire
May-06
Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference SUPN GlobeNewswire
May-05
Supernus Announces First Quarter 2026 Financial Results SUPN GlobeNewswire
Apr-22
Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026 SUPN GlobeNewswire
Feb-24
Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results SUPN +5.15% SUPN +5.67% GlobeNewswire
Feb-23
Supernus Pharmaceuticals to Participate in March Investor Conferences SUPN GlobeNewswire
Feb-12
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026 SUPN GlobeNewswire
Dec-03
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference SUPN GlobeNewswire
Nov-21
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference SUPN GlobeNewswire
Nov-12
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London SUPN GlobeNewswire
Nov-04
Supernus Announces Third Quarter 2025 Financial Results SUPN SUPN -17.35% GlobeNewswire
Oct-21
Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 SUPN GlobeNewswire
Aug-27
Supernus Pharmaceuticals to Participate in September Investor Conferences SUPN GlobeNewswire
Aug-05
Supernus Announces Second Quarter 2025 Financial Results SUPN SUPN +13.08% GlobeNewswire
Jul-31
Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics SUPN GlobeNewswire
Jul-28
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer SUPN GlobeNewswire
Jul-22
Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025 SUPN GlobeNewswire
May-29
Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree Content Series with Supernus Pharmaceuticals SUPN GlobeNewswire
May-28
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference SUPN GlobeNewswire
May-28
Supernus Announces Paragraph IV ANDA Filings for Qelbree SUPN GlobeNewswire
May-20
Busy Philipps Empowers Women with ADHD to Go from Feeling Misrepresented to Being 'Ms. Represented' in First-of-its-Kind Campaign with Supernus Pharmaceuticals SUPN GlobeNewswire
May-06
Supernus Announces First Quarter 2025 Financial Results SUPN GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)